Raymond James Financial Services Advisors, Inc. Acadia Pharmaceuticals Inc Transaction History

Raymond James Financial Services Advisors, Inc.

$66.3 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$14.2 - $18.63 $208,314 - $273,302	14,670 New	14,670 $233,000
Q2 2022 Aug 12, 2022	SELL	$13.01 - $27.22 $307,179 - $642,691	-23,611 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$20.94 - $27.5 $494,414 - $649,302	23,611 New	23,611 $572,000
Q3 2021 Nov 02, 2021	SELL	$15.78 - $24.77 $177,272 - $278,266	-11,234 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$19.4 - $27.42 $19,438 - $27,474	1,002 Added 9.79%	11,234 $274,000

Q1 2021 May 14, 2021	SELL	$25.02 - $54.99 $138,435 - $304,259	-5,533 Reduced 35.1%	10,232 $264,000
Q4 2020 Feb 12, 2021	BUY	$41.04 - $56.79 $375,351 - $519,401	9,146 Added 138.18%	15,765 $843,000
Q3 2020 Nov 04, 2020	BUY	$36.42 - $57.0 $2,840 - $4,446	78 Added 1.19%	6,619 $273,000
Q2 2020 Jul 17, 2020	SELL	$39.26 - $52.73 $65,053 - $87,373	-1,657 Reduced 20.21%	6,541 $317,000
Q1 2020 Apr 21, 2020	SELL	$31.65 - $46.87 $123,213 - $182,464	-3,893 Reduced 32.2%	8,198 $346,000
Q4 2019 Feb 12, 2020	BUY	$36.21 - $51.4 $114,061 - $161,910	3,150 Added 35.23%	12,091 $517,000
Q3 2019 Nov 07, 2019	BUY	$22.22 - $44.01 $198,669 - $393,493	8,941 New	8,941 $322,000
Q3 2018 Nov 14, 2018	SELL	$13.03 - $21.81 $513,017 - $858,703	-39,372 Closed	0 $0
Q2 2018 Jul 30, 2018	SELL	$15.07 - $22.34 $7,474 - $11,080	-496 Reduced 1.24%	39,372 $601,000
Q1 2018 Apr 16, 2018	SELL	$22.47 - $32.33 $238,631 - $343,344	-10,620 Reduced 21.03%	39,868 $896,000
Q4 2017 Feb 09, 2018	BUY	$26.84 - $39.14 $60,551 - $88,299	2,256 Added 4.68%	50,488 $1.52 Million
Q3 2017 Oct 26, 2017	BUY	$29.49 - $38.37 $68,564 - $89,210	2,325 Added 5.06%	48,232 $1.82 Million
Q2 2017 Aug 15, 2017	BUY	N/A	45,907	45,907 $1.28 Million

Others Institutions Holding ACAD

# of Institutions

299

Shares Held

158M

Call Options Held

1.88M

Put Options Held

688K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account